HTGM

HTG Molecular Diagnostics, Inc. Common Stock
HTGM

Overview Fund Activity
Delisted

HTGM was delisted on the 14th of June, 2023.

Back to rankings

24 hedge funds and large institutions have $11.2M invested in HTG Molecular Diagnostics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 3 reducing their positions, and 5 closing their positions.

Holders
24
Holders Change
+1
Holders Change %
+4.35%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
ACM
1
AIGH Capital Management
Maryland
$1.27M
2
CPA
2
Cowen Prime Advisors
New York
$2.87M
3
BWLSA
3
Blue Water Life Science Advisors
California
$375K
4
WVP
4
Worth Venture Partners
New Jersey
$299K
5
SC
5
Samjo Capital
New York
$2.35M

Top Sellers

1
GCP
1
GSA Capital Partners
United Kingdom
$0
2
Qube Research & Technologies (QRT)
2
Qube Research & Technologies (QRT)
United Kingdom
$0
3
Morgan Stanley
3
Morgan Stanley
New York
$8K
4
ASN
4
Advisory Services Network
Georgia
$0
5
BlackRock
5
BlackRock
New York
$105K
Name Market Value Shares Shares
Change 		Shares
Change %
TWA
26
TCI Wealth Advisors
Arizona
$0 26 – –
CFGS
27
Concourse Financial Group Securities
Alabama
– – – –
Osaic Holdings
28
Osaic Holdings
Arizona
$0 24 – –
Wells Fargo
29
Wells Fargo
California
$0 28 +2 +8%
Bank of America
30
Bank of America
North Carolina
$0 19 +19 New
JPMorgan Chase & Co
31
JPMorgan Chase & Co
New York
$0 34 +34 New
1
2